Evidence map›Paper›PMID 33400101›Full record

ArticleVirus genes2021

Removal of 3C protease from the 3ABC improves expression, solubility, and purification of the recombinant 3AB of foot-and-mouth disease virus.

Reda Salem, Alaa A El-Kholy, Fatma R Waly, Radwa Khaled, Wael Elmenofy

Abstract read
PubMed Publisher
In one paragraph

Article in Virus genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Reda SalemAgricultural Genetic Engineering Research Institute (AGERI), ARC, Giza, 12619, Egypt. redasalem@ageri.sci.eg.ORCID http://orcid.org/0000-0001-8579-0328
Alaa A El-KholyVeterinary Sera and Vaccines Research Institute (VSVRI), ARC, Abbassia, P.O. Box #131, Cairo, 11381, Egypt.
Fatma R WalyAgricultural Genetic Engineering Research Institute (AGERI), ARC, Giza, 12619, Egypt.
Radwa KhaledAgricultural Genetic Engineering Research Institute (AGERI), ARC, Giza, 12619, Egypt.
Wael ElmenofyAgricultural Genetic Engineering Research Institute (AGERI), ARC, Giza, 12619, Egypt.
Agricultural Genetic Engineering Research Institute · EGVeterinary Serum and Vaccine Research Institute · EG

Funding

Academy of Scientific Research and Technology National Strategy Programs for Biotechnology and Genetic Engineering (ID: 31ح/2018)
6 · The paper itself

Abstract

During an ongoing outbreak of Foot-and-Mouth Disease Virus (FMDV), it is crucial to distinguish naturally infected from vaccinated seropositive animals. This would support clinical assessment and punctual vigilance. Assays based on 3ABC non-structural protein as an antigen are reliable for this intention. However, the insolubility and degradation of recombinant 3ABC during expression and purification are serious challenges. In this study, alternatively to expressing the recombinant 3ABC (r3ABC), we expressed the 3AB coding sequence (~672 bp) as a recombinant protein (r3AB) with a molecular mass of ~26 KDa. Analytical data from three-dimensional structure, hydrophilicity, and antigenic properties for 3ABC and 3AB exhibited the 3C protein as a hydrophobic, while 3AB as a hydrophilic and highly antigenic protein. The expressed r3AB was recovered as a completely soluble matter after merely native purification, unlike the full expressed r3ABC. Immunoreactivity of r3AB to anti-FMDV antibody in infected sera with different FMDV serotypes was confirmed by the western blot and indirect ELISA. Besides, the authentic antigenicity of purified r3AB was demonstrated through its ability to induce specific seroconversion in mice. Summarily, the removal of 3C: has influenced neither 3D structure nor antigenic properties of the purified r3AB, overcame insolubility and degradation of the r3ABC, and generated a potential superior antigen (r3AB) for herd screening of animals to any FMDV serotype.

Indexed as

3C Viral ProteasesRecombinant ProteinsViral Nonstructural ProteinsAnimalsCattleCattle DiseasesFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusMice3C Viral ProteasesRecombinant ProteinsViral Nonstructural Proteins3C removalBacterial gene expressionFMDVImmunoreactivityInsolubilityNon-structural 3ABCRecombinant 3AB

Identifiers

PMID33400101
OpenAlexW3118513741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.